Efficacy of Nitrous Oxide in OCD: Pilot Study

Recruiting Phase 2 Interventional Study
Obsessive-Compulsive Disorder
Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 65
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Treatment
Participants needed
45 (estimated)
Sponsor
Stanford University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study investigates whether the commonly used and well-tolerated inhaled anesthetic nitrous oxide can rapidly improve symptoms of OCD.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age 18-65 * Primary diagnosis of OCD * Sufficient severity of OCD symptoms * Ability to tolerate a treatment-free period * Capacity to provide informed consent Exclusion Criteria: * Psychiatric or medical conditions that make participation unsafe * Pregnant or nursing female…
Contacts

Pavithra Mukunda, MS

650-723-4095

ocdresearch@stanford.edu

CONTACT

Sindu Menon, MBBS

650-723-4095

ocdresearch@stanford.edu

CONTACT